NCT03898063

Brief Summary

This investigation seeks to understand if and how, the 90 Days film can be used as an intervention to address HIV-related stigmas, intimate partner status disclosure and HIV ART medical adherence among Black HIV positive women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 1, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

June 17, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2020

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

July 2, 2021

Completed
Last Updated

July 2, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

March 29, 2019

Results QC Date

May 17, 2021

Last Update Submit

June 11, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • HIV Self-stigmatization as Assessed Via Self Stigmatization Questionnaire

    self-report measure of the extent to which participants stigmatize themselves for being HIV positive. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher perceptions of self-stigmatization.

    Day 1 post test

  • HIV Disclosure Intentions as Assessed by Disclosure Intentions Scale

    Self-report measure of the extent to which participants intend to disclose their HIV status to a partner. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher intentions of status disclosure.

    Day 1 post-test

  • Medical Adherence Intentions as Measured by the Medical Adherence Scale

    Self-report measure of participants likeliness to miss doses of their antiretroviral medication over a 30 day period. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating increased likeliness to miss doses of antiretroviral medication.

    Day 1 post-test

Study Arms (2)

Control

ACTIVE COMPARATOR

participants will receive a standard-of-care brochure detailing HIV status disclosure.

Behavioral: HIV pamphlet on disclosure

intervention: 90 DAYS film

EXPERIMENTAL

participants will watch the film, 90 DAYS

Behavioral: 90 DAYS film

Interventions

90 DAYS filmBEHAVIORAL

the intervention conditions include exposure to a film, 90 DAYS (approx 20 minutes long), an entertainment film detailing a woman's decision to tell her romantic partner that she is HIV-positive.

intervention: 90 DAYS film

A standard-of-care brochure given to newly diagnosed HIV patients about the importance of status disclosure

Control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Black women ages 18-50
  • clinically diagnosed with HIV/AIDS
  • Speak and comprehend English

You may not qualify if:

  • pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami Medical Campus

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Nick Carcioppolo
Organization
University of Miami

Study Officials

  • Nicholas Carcioppolo, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 29, 2019

First Posted

April 1, 2019

Study Start

June 17, 2019

Primary Completion

May 31, 2020

Study Completion

May 31, 2020

Last Updated

July 2, 2021

Results First Posted

July 2, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations